Alternatives to CairnSurgical

Uses AI and IoT technologies to develop wearable medical devices for personalized health insights.

Develops an AI-driven surgical navigation platform using 3D ultrasound for enhanced cancer treatment.

Develops AI-driven, real-time intraoperative imaging for early lung cancer diagnostics and treatment.

TechsoMed develops ultrasound-based real-time monitoring systems for thermal ablation procedures, enhancing safety and efficacy.

Developing a new histotripsy therapeutic platform for cancer treatment.

Liger Medical develops breakthrough optical diagnostic devices and software for early cancer detection and other medical purposes.

Develops and commercializes minimally invasive robotic platforms for the neuroscience field.

AI-powered cancer detection and therapy solutions for early diagnosis and personalized risk assessment.

Digital pathology imaging technology and AI-driven precision pathology software.

Developing minimally invasive water vapor ablation therapy to treat prostate, kidney, and bladder cancer.

Develops innovative surgical technology to make bone surgery safer and more precise by protecting soft tissues.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

Radiaction Medical revolutionizes radiation protection for interventional medical teams with innovative, user-independent shielding solutions.

Zsquare develops the world's thinnest, high-resolution micro-endoscopes for various medical applications, enabling disposable and cost-effective procedures.

A global medical technology, diagnostics, and digital solutions innovator, providing integrated solutions for precision health.

Organox develops and commercializes medical devices for organ preservation and assessment, aiming to improve outcomes for transplant patients.

AI-powered blood test for early cancer detection and subtyping.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.